Biofrontera Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Biofrontera Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q3 2024.
- Biofrontera Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $3K, a 200% increase year-over-year.
- Biofrontera Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $18K.
- Biofrontera Inc. annual Income Tax Expense (Benefit) for 2023 was $14K, a 56.3% decline from 2022.
- Biofrontera Inc. annual Income Tax Expense (Benefit) for 2022 was $32K, a 42.9% decline from 2021.
- Biofrontera Inc. annual Income Tax Expense (Benefit) for 2021 was $56K, a 12.5% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)